ClinVar Miner

Variants in gene GGPS1

Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
5 1 23 0 0 27

Condition and significance breakdown #

Total conditions: 7
Download table as spreadsheet
Condition pathogenic likely pathogenic uncertain significance total
not specified 0 0 10 10
Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome 5 0 4 9
not provided 0 0 6 6
Neuromuscular disease 0 0 2 2
Myopathy with tubular aggregates 0 1 0 1
Sensorineural hearing loss disorder; Myopathy 0 0 1 1
Sensorineural hearing loss disorder; Myopathy; Premature ovarian insufficiency 0 0 1 1

Submitter and significance breakdown #

Total submitters: 10
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance total
Ambry Genetics 0 0 10 10
OMIM 5 0 0 5
GeneDx 0 0 4 4
Baylor Genetics 0 0 2 2
Labcorp Genetics (formerly Invitae), Labcorp 0 0 2 2
Undiagnosed Diseases Network, NIH 0 0 2 2
Reproductive Development, Murdoch Childrens Research Institute 0 0 2 2
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard 0 0 2 2
Neuberg Centre For Genomic Medicine, NCGM 0 0 2 2
Muscle and Diseases Team, Institut de Génétique et Biologie Moléculaire et Cellulaire 0 1 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.